BACKGROUND
The pharmacokinetics of inhaled anaesthetics are usually described by the F A /F I over time ([F A /F I ]/dt) curve. This curve describes the evolution of the alveolar partial pressure (expressed as fraction of 1 atmosphere, F A ) towards the inspired partial pressure (F I ) over time 1 . Factors affecting the kinetics of inhaled anaesthetics affect the rise (curve shift upwards or downwards) and rate of rise ([F A /F I ]/dt, the steepness of the upslope) of the F A /F I curve. The effects of blood solubility, cardiac output and ventilation on the F A /F I curves are basic kinetic concepts that are learned early during anaesthesia training 1 . The effect of these parameters on the course of F A /F I is thought to reflect how these factors affect wash-in of the central nervous system and, therefore, speed of induction because F A is the partial pressure that corresponds closest to the central nervous system inhaled agent level. Therefore, F A is related to the clinical end-points of immobility and hypnosis as described by minimum alveolar concentration (MAC) and MACawake 'concepts', respectively 2, 3 . Anaesthetists are thoroughly familiar
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The effects of blood solubility, cardiac output and ventilation on the rise of the alveolar towards the inspired concentration, the F A /F I curve, of an inhaled anaesthetic are often thought to reflect how these factors affect wash-in of the central nervous system compartment and, therefore, speed of induction because F A is the partial pressure ultimately attained in the central nervous system (F VRG ). These classical F A /F I curves assumed a constant F I . We used GasMan ® to examine whether changes in solubility, cardiac output and ventilation affect the relationship between the F A /F I curve and F VRG differently while either F I or F A are kept constant.
Using GasMan ® , we studied the effects of solubility (desflurane vs isoflurane), cardiac output (5 vs 10 l.min -1 ) and minute ventilation (4 
vs 8 l.min -1 ) on F A , F I , F A /F I and F VRG with either F I kept constant or F A kept constant (at 1 minimum alveolar concentration). High fresh gas flows were used to avoid rebreathing, so that the delivered concentration matched F I . Despite similar effects on the F A /F I curve, the effects on F VRG differed. With constant F I , lower solubility or higher ventilation results in a higher F VRG and a higher cardiac output results in a lower F VRG . With constant F A , solubility has only a minimal effect on F VRG ; an increase in cardiac output hastens the rise of F VRG to the same plateau value; and a change in ventilation has minimal effect on F VRG .
Despite similar effects on the F A /F I curve, the effects of solubility, cardiac output and ventilation on the F VRG are different when either F I or F A are kept constant. With the F I kept constant, induction of anaesthesia is slower with a higher cardiac output, but with F A kept constant, induction of anaesthesia is faster with a higher cardiac output. The introduction of an end-expired closed-loop feedback administration of inhaled anaesthetics makes this distinction clinically relevant.
with all these concepts and multi-gas analysers readily display F A and F I in the operating room. However, the classical F A /F I curves are based on the delivery of anaesthetics using a high fresh gas flow (FGF) and a constant vaporiser setting, which results in a constant F I . Therefore, the F A /F I curves may not reflect the underlying organ kinetics in the same way when closed-loop end-expired feedback administration is used, which focuses on maintaining a certain (constant) F A by manipulating F I . This technology is implemented, for example, in the Zeus anaesthesia machine (Dräger, Lubeck, Germany) 4 . In this paper, GasMan ® (Med Man Simulations Inc., Chestnut Hill, MA, USA) was used to examine whether differences in blood solubility, cardiac output and ventilation independently affect the relationship between F A /F I and the partial pressure in the vesselrich group (F VRG ) during constant F I and constant F A control. For the purposes of this paper, the partial pressure in the central nervous system is considered to be the same as that in the vessel-rich group (VRG) and the terms alveolar and end-expired are used interchangeably because the GasMan ® program does not incorporate a separate dead space ventilation correction function. Although the simulation only approximates actual in vivo conditions, the purpose of this paper is to provide additional insight into the kinetics of potent inhaled anaesthetics. More specifically, we examine how changes in solubility, cardiac output and ventilation differently affect F VRG when either F A or F I are kept constant and thus warrant a different interpretation of the F A /F I curve.
METHODS
GasMan ® , a computer program, is a physiologically-based model of inhaled anaesthetic uptake and distribution. Agent solubility in blood and tissues, gas and blood flows, and compartment volumes (lungs, VRG, muscle group and fat group) determine the rate of agent transfer 5, 6 . The version used in this study does not correct for inter-tissue diffusion, anaesthetic metabolism, dead space or ventilation/perfusion abnormalities. The GasMan ® program allows the user to manipulate the vaporiser setting (F D ) of an agent of choice, FGF, circuit volume, ventilation and cardiac output, and to observe the resulting course of F I and F A and the partial pressure of the potent inhaled anaesthetic in several tissues (arterial and venous blood, VRG, muscle group and fat group). Three different scenarios were studied, with the following program settings kept constant for all simulations: a 70 kg patient, an anaesthesia breathing circuit volume of 8 l and a FGF of 8 l.min -1 . High FGF was used to avoid rebreathing, so that the delivered concentration matched F I .
First, the effect of using agents with different blood solubility was studied. While maintaining either F A or F I constant at 1 MAC, isoflurane or desflurane was administered to a patient with a cardiac output of 5 l.min -1 and a minute ventilation of 4 l.min -1 . Next, the effect of cardiac output was simulated by choosing a cardiac output of 5 or 10 l.min -1 while maintaining either desflurane F A or F I constant at 1 MAC while also keeping minute ventilation at 4 l.min -1 . Finally, the effect of ventilation was examined by using a minute ventilation of 4 or 8 l.min -1 while maintaining desflurane F A or F I constant at 1 MAC while also keeping cardiac output at 5 l.min -1 . When performing the simulation, it is easy to keep F I constant but, to keep F A constant, the F D setting has to be continuously adjusted, which causes small oscillations.
F A /F I values were calculated from F I and F A and F A /F I versus time curves were constructed. We then examined by visual inspection how differences in blood solubility, cardiac output and ventilation affect the F A /F I versus time curves and the F VRG under conditions of constant F I and constant F A .
RESULTS
When F I is kept constant, F A is higher with the less soluble agent (desflurane) ( Figure 1L 1 ) ; F A is lower with a higher cardiac output (Figure 2L 1 ) and F A is higher with a higher minute ventilation ( Figure  3L 1 ). When F A is kept constant, F I has to be higher by design but F I is relatively higher for isoflurane than for desflurane ( Figure 1R 1 ) . The F I required to achieve the desired F A is higher when cardiac output is higher ( Figure 2R 1 ) and F I is lower when ventilation is higher (Figure 3R 1 (Figures 1L 3 and 3L 3 , respectively) . With a higher cardiac output, the F VRG is higher at two to six minutes, but ultimately results in a lower F VRG (Figure 2L 3 ). Once F A is controlled, t. van the difference in blood solubility between isoflurane and desflurane has only a minimal effect on F VRG (Figure 1R 3 ) ; an increase in cardiac output hastens the rise of F VRG to the same plateau value ( Figure 2R 3 ) and a change in ventilation has minimal effect on F VRG (Figure 3R 3 ).
DISCUSSION
Our GasMan ® simulation illustrates how the mode of administration of potent inhaled anaesthetics differently affects the impact of blood solubility, cardiac output and ventilation on the rise and rate of rise of the F VRG , even though their effect on the F A /F I curve is qualitatively the same.
With both the constant F I and constant F A techniques, the F A /F I versus time curve is lower for isoflurane (with the greater blood and tissue solubility) than for desflurane ( Figures 1L 2 and  1R 2 ). When keeping F I constant, the isoflurane F A rises more slowly than that of desflurane because uptake by the blood is higher (as a result of higher tissue uptake). Consequently, F VRG of isoflurane rises slower than that of desflurane, suggesting that induction would be slower with isoflurane fIgure 1: Effect of blood solubility on F A , F I , F A /F I and F VRG over time with two different modes of administration. The graphs on the left represent the constant F I mode of administration, those on the right the constant F A mode of administration. See text for details. In Figure  1L 1 the F I des and F I iso data points are overlapping. In Figure 1R 1 the F A des and F A iso data points are overlapping.
( Figure 1L 3 ). When using a constant F A technique, the difference between the course of F VRG of desflurane and isoflurane is minimal because a feedback system (e.g. an anaesthetist using the overpressure technique; an automated anaesthesia machine) 'automatically' supplies the relatively larger amounts taken up of the more soluble agent by increasing F D and therefore F I (Figure 1R 3 ) . As a result, with a constant F A technique, the rate of rise of F VRG becomes almost independent of blood solubility. Indeed, the rate of rise of F VRG is then determined by the capacity of the VRG tissues (determined by tissue solubility and volume of the VRG tissues) and by the transport function of the blood (determined by blood solubility and blood flow to the VRG tissues). A lower 'tissue capacity' (lower tissue solubility) will result in a faster rise of F VRG but a lower transport of the agent to the tissue (lower blood solubility) will slow the rise of F VRG . A higher cardiac output increases desflurane uptake by transferring more desflurane to unsaturated tissues and therefore decreases the rate of rise of F A towards F I : the F A /F I curves are fIgure 2: Effect of cardiac output on F A , F I , F A /F I and F VRG over time with two different modes of administration. The graphs on the left represent the constant F I mode of administration, those on the right the constant F A mode of administration. See text for details. In Figure  2L 1 the F I normal CO and F I high CO data points are overlapping. In Figure 2R 1 the F A normal CO and F A high CO data points are overlapping.
cardiac output, the arterial partial pressure and therefore F VRG is lower because the F A with which it equilibrates is lower. Consequently, induction is expected to be slower with a higher cardiac output ( Figure 2L 3 ). With the constant F A technique, the F A /F I is also decreased when cardiac output is high, but mainly because F I has to be increased in order to keep the F A constant. Thus, in this case, the cause for the lowered F A /F I is the increase in F I (Figure 2R 1 ) . Equilibration between the arterial blood and the VRG is also faster, but because a feedback system (anaesthetist or automated shifted down with either a constant F I or constant F A technique ( Figures 2L 2 and 2R 2 ). With the constant F I technique, F VRG is initially higher with higher cardiac output because there is rapid transfer of agent from the alveoli to the VRG tissues despite the lower F A . However, after a few minutes, the effect of the lower F A comes into play and F VRG with high cardiac output becomes lower than the F VRG with low cardiac output. All this results in an ultimately slower induction with a higher cardiac output ( Figure 2L 3 ) . While equilibration between the arterial blood and the VRG is faster with a high fIgure 3 : Effect of ventilation on F A , F I , F A /F I and F VRG over time with two different modes of administration. The graphs on the left represent the constant F I mode of administration, those on the right the constant F A mode of administration. See text for details. In Figure 3L 1 the F I normal V and F I high V data points are overlapping. In Figure 3R 1 the F A normal V and F A high V data points are overlapping. anaesthesia machine) 'automatically' supplies the larger amounts taken up in the hyperdynamic patient by increasing F I (and thus keeping F A constant), a higher cardiac output hastens desflurane wash-in of the VRG towards that constant F A (Figure 2R 3 ). This suggests that induction would be faster with a higher cardiac output. This is somewhat analogous to what happens with intravenous agents. An increase in ventilation raises the F A /F I curves with both techniques ( Figures 3L 2 and 3R 2 ). With the constant F I technique, an increase in ventilation results in a faster rise of F A and, therefore, F VRG , suggesting that induction will be faster ( Figure 3L 3 ). With the constant F A technique however, an increase in ventilation will result in only a slightly faster rise of F VRG , because higher ventilation will merely hasten lung wash-in (Figure 3R 3 ). The simulation does not include the possible effects of hyperventilation on cerebral blood flow, which could influence the rate of rise of F VRG .
Our GasMan ® simulation illustrates that when F A is kept constant, 1) the difference in the rise of F VRG between agents with a different blood solubility becomes dependent on the relative values of tissue solubility and blood solubility, 2) a higher cardiac output accelerates the rise of F VRG and 3) a change in ventilation has minimal effect on the course of F VRG .
This interpretation is different from the classical interpretation of the F I /F A curve, which suggests that the speed of induction (rise of F VRG ) is slower with the use of an agent with higher blood solubility, higher cardiac output and lower ventilation. Besides being of theoretical interest, this difference is clinically relevant with anaesthesia machines that use closed-loop end-expired feedback administration of inhaled anaesthetics, where the equipment determines the F D required to obtain the desired F A . One only needs to consider the examples of a patient with a low cardiac output (e.g. shock) or a hyperdynamic state (e.g. sepsis, burns, liver failure) producing the opposite effect of cardiac output on the course of F VRG with the constant F A versus constant F I technique to realise the potential implications.
In clinical practice we often use a hybrid approach: we first allow F A to gradually rise towards F I (often while the effect of intravenous induction agents is waning) and, once the desired F A is reached, we adjust F I to maintain F A at the desired value. The difficulty comes in when FGF is lowered. Re-breathing causes a discrepancy between F D and F I . The lower the FGF, the larger the discrepancy between F D and F I . This may have potentially deterred many anaesthesiologists from using lower FGF and may have been the impetus for the development of modern closed-loop end-expired feedback anaesthesia machines. These machines take over this task, allowing better and more rapid control of F A under low-flow conditions. This shift of focus demands an interpretation of the F A /F I curve which is different to what has traditionally been used to describe kinetics of inhaled agents.
CONCLUSION
In summary, the mode of administration of potent inhaled anaesthetics alters the impact of changes in blood solubility, cardiac output and ventilation on the rate of rise of F VRG . When F I is kept constant, F VRG will rise faster and higher with an agent with a lower solubility, lower cardiac output and higher ventilation. This results in an ultimately slower induction with a higher cardiac output. However, when F A is kept constant, the course of F VRG is minimally affected by solubility and ventilation but F VRG will rise faster towards the same F A with a higher cardiac output. Thus, when F A is kept constant, induction of anaesthesia is faster with a higher cardiac output. Because the effects of changes in solubility, cardiac output and ventilation on F A /F I are similar when either F I or F A are kept constant yet have different effects on the F VRG , care has to be taken when making inferences from the F A /F I curve regarding the effect of these parameters on depth of anaesthesia or speed of induction. It should not be overlooked, however, that the ultimate factor determining speed of induction depends mainly on the absolute F A , which is not represented by the F A /F I curve.
